[img_inline align=”right” src=”http://padnws01.mcmaster.ca/images/Young,-Edward-2005.jpg” caption=”Edward Young”]Edward Young, a professor in the Department of Pathology and Molecular Medicine, has been named this year's winner of the Canadian Society of Clinical Chemists (CSCC) award, which recognizes outstanding achievement in the field of clinical chemistry.

Young is the discipline director of clinical chemistry and immunology for the Hamilton Regional Laboratory Medicine Program (HRLMP), which is a collaboration between Hamilton Health Sciences, St. Joseph's Healthcare, and McMaster University.

“Dr. Young is a very worthy recipient of this award, and has made a vital contribution to chemistry in his areas of study,” says Matthew McQueen, director of HRLMP and a professor in pathology and molecular medicine at McMaster. “I wish him continued success in his future academic and professional activities in Canada and internationally.”

Young is a clinical biochemist whose major research interests are in the biochemistry and physiology of heparin, an anticoagulant used in the prevention and treatment of thrombosis and pulmonary embolism. His research has helped to explain the effect of heparin-binding proteins in plasma and their role in the variability of the anticoagulant response to heparin and to the phenomenon of heparin resistance.

He is also an active student advisor at McMaster University, continues to serve on several supervisory committees, and has completed terms on various boards.

The award was presented at the XIX International Congress on Clinical Chemistry, co-hosted by the Canadian Society of Clinical Chemists, being held in Orlando, Fla., last month.